Lipocine (LPCN) Payables (2011 - 2025)
Lipocine (LPCN) recorded Payables of $971,822 in Q4 2025, up 257.7% from $271,696 a year earlier and up 12.8% from the prior quarter.
Analysis
Lipocine (LPCN) Payables (2011 - 2025) Analysis & Trends
Starting with Q4 2011, Lipocine's Payables history includes 56 quarters.
- Annual Payables has a five-year compound annual growth rate of -9.5% (FY2020 to FY2025).
- Across earlier years, Payables came in at $271,696 in FY2024 (-80.5%), $1.4 million in FY2023 (+132.5%), $600,388 in FY2022 (-53.4%) and $1.29 million in FY2021 (-19.3%).
- The Q4 2025 figure is the highest quarterly Payables since Q4 2023.
- On a year-over-year basis, Payables rose in two of the last eight quarters, with growth averaging 28.5%.
- Peak year-over-year performance for Payables in the last five years was growth of 257.7% in Q4 2025, against a decline of 80.5% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $861,452 (Q3 2025), $442,994 (Q2 2025) and $360,239 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Lipocine | 11.33 Mn | -56.39 Mn | - | 971,822.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 971,822.00 |
| Sep 30, 2025 | 861,452.00 |
| Jun 30, 2025 | 442,994.00 |
| Mar 31, 2025 | 360,239.00 |
| Dec 31, 2024 | 271,696.00 |
| Sep 30, 2024 | 285,347.00 |
| Jun 30, 2024 | 448,798.00 |
| Mar 31, 2024 | 671,445.00 |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 517,587.00 |
| Mar 31, 2023 | 796,476.00 |
| Dec 31, 2022 | 600,388.00 |
| Sep 30, 2022 | 630,456.00 |
| Jun 30, 2022 | 814,004.00 |
| Mar 31, 2022 | 469,887.00 |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 725,552.00 |
| Jun 30, 2021 | 906,476.00 |
| Mar 31, 2021 | 558,344.00 |
API Access
Lipocine Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=LPCN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();